#Canada #Toronto #cognitive health #Creyos #Redox

Transforming Cognitive Health Care with Technology

A Strategic Partnership

In a groundbreaking move, Creyos, a front-runner in cognitive and behavioral health assessments, has announced a partnership with Redox, a key player in healthcare data integration. This collaboration marks a significant milestone in how cognitive screenings are incorporated into routine health care, particularly within electronic health record (EHR) systems. As global awareness around cognitive health rises, this partnership comes at a crucial time.

The Importance of Cognitive Assessments

Currently, over 55 million individuals are estimated to be living with dementia, with numbers projected to climb to 139 million by 2050. The pressing need for early diagnosis and preventive measures in brain health is, therefore, paramount. Cognitive assessments enable health professionals to develop personalized care plans and implement timely interventions to improve patient outcomes. However, integrating such assessments into routine care has been challenging for many health systems.

Bridging the Gap

Historically, healthcare technology struggles to align with the workflows of large health systems. Creyos is positioning itself to change this narrative by collaborating with Redox, which connects with over 90 EHR systems, including major names like Cerner, eClinicalWorks, and Allscripts. This means that health systems utilizing Creyos will seamlessly embed cognitive health evaluations into their existing framework, eliminating technical hurdles that have limited growth in this area.

Key Benefits of the Integration

The synergies from this partnership bring several advantages:

• - Timely Decision-Making: Providers will have immediate access to cognitive assessment data within their existing EHR systems, facilitating quicker clinical decisions and interventions.
• - Enhanced Workflow Efficiency: By automating data integration, the administrative workload is significantly reduced, allowing clinicians to devote more time to patient interaction and care quality.
• - Scalability: Whether a small clinic or a national health organization, the Creyos-Redox integration can be tailored to the needs of any enterprise, enhancing cognitive health screenings at scale.
• - Early Detection: Integrating cognitive assessments directly into medical practices enables health professionals to monitor cognitive health over time, leading to prompt detection of disorders such as dementia and mild cognitive impairment (MCI).

Shifting Perspectives on Cognitive Health

According to Marc Lipton, CEO of Creyos, this partnership signifies a pivotal change in the approach to cognitive healthcare. He states, "To deliver on the promise of value-based care, we need tools that work not just clinically but operationally. Our collaboration with Redox breaks down the barriers that have hindered adoption for years. It places our assessments exactly where they should be: in the systems clinicians already depend on."

A Healthier Tomorrow

The integration of Creyos' assessments into EHRs through Redox is expected to change the landscape of cognitive health care, making it more accessible to patients and healthcare providers alike. As highlighted by Trip Hofer, CEO of Redox, timely and connected care is the future of healthcare. By embedding cognitive assessments in everyday clinical workflows, providers can intervene sooner, leading to better outcomes for patients.

This partnership is now open to all Creyos customers, enabling health systems to enhance their practices with essential cognitive health tools effectively. Anyone interested in learning more can visit creyos.com for additional information.

Together, Creyos and Redox are redefining the future of cognitive healthcare, making significant strides in improving the quality and accessibility of brain health assessments for millions worldwide.